GGrantIndex
Sort

50,496 grants matching lung cancer

Improved Staging of Pancreatic Cancer

$406,658
Ralph Weissleder · Dana-Farber Cancer Inst · P50 · FY2008 · CA

Controlled Release of Macromolecules

$406,614
Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2009 · EB

Immune cell control of ovarian cancer

$406,610
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Mechanisms of Normal Tissue Toxicity

$406,583
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Ligand-mediated, vehicle-free delivery of small RNAs

$406,567
Andrea L Kasinski · Purdue University · R01 · FY2020 · CA

BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma

$406,527
David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Hydrolytic enzymes in the metabolism of toxins

$406,522
Bruce D Hammock · University Of California At Davis · R01 · FY2015 · ES

HLA LOH Detection via Liquid Biopsy: A Blood-Based Predictive Biomarker Assay for Precision Immuno-Oncology

$406,500
Andrew Sinkoe · Sesh Incorporated · U43 · FY2025 · CA

Overcoming Breast Cancer Therapeutic Resistance by Multifunctional RNA Nanoparticles

$406,500
Xiaoting Zhang · Rna Nanotherapeutics Llc · R41 · FY2022 · CA

Development of a novel, targeted small molecule inhibitor of the nucleoside salvage pathway through murine studies to enable further clinical advancement in non-small-cell lung cancer

$406,500
Kenneth Schultz · Trethera Corporation · R44 · FY2025 · CA

Effect of the Spiroiminodihydantoin Lesion on DNA Base Pair Opening Dynamics, Nucleosome Assembly, and Base Excision Repair

$406,477
Elizabeth Redding Jamieson · Smith College · R15 · FY2019 · CA

Ligand-mediated, vehicle-free delivery of small RNAs

$406,459
Andrea L Kasinski · Purdue University · R01 · FY2021 · CA

Multidisciplinary research training in pulmonary diseases

$406,452
Claire M Doerschuk · Univ Of North Carolina Chapel Hill · T32 · FY2012 · HL

More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

$406,379
Benzi M Kluger · University Of Colorado Denver · R01 · FY2018 · NR

Synaptic and circuit mechanisms of olfactory processing

$406,375
Rachel Wilson · Harvard Medical School · R01 · FY2006 · DC

KLF9-TXNRD2 axis in melanoma progression and metastasis

$406,373
Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA

Inhalable amphotericin B nanodisk therapy for aspergillosis in HIV-infected patie

$406,373
Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2008 · AI

Translational Research Training in Environmental Medicine

$406,274
William N Rom · New York University School Of Medicine · T32 · FY2009 · ES

Center for Clinical and Translational Sciences (CCTS)

$406,245
David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2020 · TR

Impact of heterogeneity on response to EGFR T790M inhibitors

$406,220
Lecia V. Sequist · Massachusetts General Hospital · R01 · FY2017 · CA

Impact of heterogeneity on response to EGFR T790M inhibitors

$406,220
Lecia V. Sequist · Massachusetts General Hospital · R01 · FY2016 · CA

Impact of heterogeneity on response to EGFR T790M inhibitors

$406,220
Lecia V. Sequist · Massachusetts General Hospital · R01 · FY2018 · CA

Impact of heterogeneity on response to EGFR T790M inhibitors

$406,220
Jeffrey A Engelman · Massachusetts General Hospital · R01 · FY2015 · CA

Metabolic Studies of Mouse Models of Obesity and Diabetes

$406,195
Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2018 · DK

Light-directed therapy of squamous cell head and neck cancer with a novel dual-acting chemotherapeutic.

$406,186
Matthew C Hartman · Light Switch Bio, Llc · R41 · FY2023 · CA